Viewing Study NCT06892002

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:39 AM
Ignite Modification Date: 2026-01-28 @ 11:33 PM
Study NCT ID: NCT06892002
Status: COMPLETED
Last Update Posted: 2025-08-15
First Post: 2025-01-24
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Description of Patients With Type 1 Diabetes Treated With Teplizumab
Sponsor: Sanofi
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 1 Diabetes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Teplizumab View
None Type 1 Diabetes View
None Real-world study View
None Stage 2 Type 1 Diabetes View
None Stage 3 Type 1 Diabetes View
None Disease progression View
None Treatment patterns View
None Patient monitoring View